We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

158 hedge funds and large institutions have $830M invested in Aerie Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 61 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 19

38% more capital invested

Capital invested by funds: $601M → $830M (+$229M)

5% more funds holding

Funds holding: 150 → 158 (+8)

25% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 61

25% less call options, than puts

Call options by funds: $3.8M | Put options by funds: $5.06M

Holders
158
Holders Change
+8
Holders Change %
+5.33%
% of All Funds
2.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
46
Reduced
61
Closed
19
Calls
$3.8M
Puts
$5.06M
Net Calls
-$1.26M
Net Calls Change
-$2.71M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$37.3M
2
GIM
Granahan Investment Management
Massachusetts
+$14.3M
3
Principal Financial Group
Principal Financial Group
Iowa
+$9.14M
4
RCMNY
Rubric Capital Management (New York)
New York
+$8.3M
5
ACM
Atika Capital Management
New York
+$8.29M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11.5M
2
VOYA Investment Management
VOYA Investment Management
Georgia
-$7.87M
3
First Manhattan
First Manhattan
New York
-$6.14M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$5.91M
5
Bank of America
Bank of America
North Carolina
-$5.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
51
Two Sigma Advisers
New York
$2.17M +$2.1M +121,600 New
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$2.13M +$1.1M +63,717 +114%
FIM
53
Freedom Investment Management
Connecticut
$2.12M +$2.04M +118,382 New
RA
54
Royce & Associates
New York
$2.1M +$2.03M +117,650 New
PPA
55
Parametric Portfolio Associates
Washington
$2M +$103K +5,981 +6%
CM
56
Caption Management
Oklahoma
$1.68M +$1.62M +93,808 New
DA
57
DCF Advisers
Connecticut
$1.65M +$993K +57,500 +164%
Swiss National Bank
58
Swiss National Bank
Switzerland
$1.63M +$27.6K +1,600 +2%
Citadel Advisors
59
Citadel Advisors
Florida
$1.57M -$4.57M -264,315 -75%
Stifel Financial
60
Stifel Financial
Missouri
$1.53M -$175K -10,115 -11%
JAMONY
61
Jacob Asset Management of New York
California
$1.49M +$311K +18,000 +28%
MWVC
62
Morgens Waterfall Vintiadis & Co
New York
$1.43M – – –
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$1.35M -$120K -6,937 -8%
Millennium Management
64
Millennium Management
New York
$1.34M -$1.43M -82,965 -53%
CSS
65
Cubist Systematic Strategies
Connecticut
$1.29M -$354K -20,505 -22%
Envestnet Asset Management
66
Envestnet Asset Management
Illinois
$1.26M +$129K +7,461 +12%
TLP
67
Tri Locum Partners
New York
$1.22M +$1.18M +68,472 New
NIM
68
NXG Investment Management
Texas
$1.22M +$832K +48,166 +240%
PP
69
PDT Partners
New York
$1.11M -$32.2K -1,867 -3%
AllianceBernstein
70
AllianceBernstein
Tennessee
$1.06M -$123K -7,100 -11%
Dimensional Fund Advisors
71
Dimensional Fund Advisors
Texas
$1.02M -$236K -13,684 -19%
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
$989K – – –
State of Wisconsin Investment Board
73
State of Wisconsin Investment Board
Wisconsin
$936K -$1.57M -90,658 -63%
Russell Investments Group
74
Russell Investments Group
United Kingdom
$914K -$903K -52,290 -51%
CS
75
Credit Suisse
Switzerland
$874K +$120K +6,922 +16%
1 2
3
4 5

AERI Hedge Fund Activity: Q1 2021 in Review

158 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q1 2021, worth a combined $830M — up 38% from $601M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AERI positions and 19 closed out — a net gain of 9 holders — while 46 added to existing stakes and 61 trimmed.

The largest buyer was Woodline Partners, opening a new position worth an estimated $37.3M. The largest seller was Deerfield Management, cutting an estimated $11.5M.

  • 158 institutional investors held Aerie Pharmaceuticals (AERI) as of Q1 2021, up from 150 in Q4 2020.
  • Funds reported $830M of Aerie Pharmaceuticals stock for Q1 2021, up 38% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q1 2021 and 19 closed out, a net change of +9 holders.
  • The largest Aerie Pharmaceuticals buyer in Q1 2021 was Woodline Partners, an estimated $37.3M added.
  • The largest Aerie Pharmaceuticals seller in Q1 2021 was Deerfield Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q1 2021.